Gastrointestinal Associates, PA

Flowood, Mississippi 39232

1 studies enrolling now · 8 studies all time

What they study most

Erosive Esophagitis, Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome Characterized by Constipation, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Non Alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Ulcerative Colitis

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old — Stopped early
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• A Phase 2b Study of Icosabutate in Fatty Liver Disease — Completed
• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Completed
• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis — Completed